Key considerations in the diagnosis and treatment of pancreatic cystic tumors
10.3760/cma.j.cn112139-20250121-00039
- VernacularTitle:胰腺囊性肿瘤诊治过程中应注意的几个问题
- Author:
Shanmiao GOU
1
;
Heshui WU
1
Author Information
1. 华中科技大学同济医学院附属协和医院胰腺外科，武汉430022
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Diagnosis;
Antineoplastic protocols;
Pancreatic cystic neoplasms;
Serous cystic neoplasms;
Mucinous cystic neoplasms;
Intraductal papi
- From:
Chinese Journal of Surgery
2025;63(8):677-681
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cystic neoplasm (PCN) has multiple pathological types, with an increasing incidence year by year. PCN exhibits strong heterogeneity, and the risk of malignancy and malignant transformation varies significantly among different pathological types. Additionally, pancreatic resection carries high surgical risks, so multiple factors must be considered when making treatment decisions for PCN. Among various pathological types of PCN, intraductal papillary mucinous tumors, mucinous cystic neoplasms, and serous cystic neoplasms share similar imaging characteristics and relatively high incidence rates, but their treatment strategies differ markedly. This article, based on recommendations from domestic and international guidelines, literature reviews, and the author′s clinical experience, offers insights and solutions to the challenges in diagnosing and treating these three types of PCN. It emphasizes that it is essential to diagnose as accurately as possible through existing examination methods and MDT discussions; for patients who cannot be definitively diagnosed and have no risk factors, a close follow-up strategy should be adopted, and surgery should not be performed arbitrarily.
